Genetic and environmental influence on diabetic rat embryopathy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 3, 2011, Pages

  Ejdesjo A ^a   Wentzel, P ^a   Eriksson, U J ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Aldose reductase; Animal experimentation; Antioxidative enzymes; Congenital abnormalities; Diabetes in pregnancy; Glial derived neurotrophic factor; Glyceraldehyde 3 phosphate dehydrogenase; Ret proto oncogene; Sonic hedgehog homolog; Teratology

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BONE MORPHOGENETIC PROTEIN 4; BRANCHED CHAIN AMINO ACID; FRUCTOSAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN RET; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYOPATHY; ENVIRONMENTAL FACTOR; FEMALE; FETUS HEART; FETUS MALFORMATION; FETUS OUTCOME; FETUS RESORPTION; GENE EXPRESSION; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE BLOOD LEVEL; HEREDITY; MATERNAL DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDEHYDE REDUCTASE; AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; ENVIRONMENT; FEMALE; FETAL DISEASES; FETUS; GENOTYPE; GLUTATHIONE PEROXIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; ISOPROSTANES; LIPID METABOLISM; LIVER; MALE; PREGNANCY; PREGNANCY IN DIABETICS; RATS; RATS, INBRED WF; RATS, SPRAGUE-DAWLEY; RNA; SUPEROXIDE DISMUTASE;

EID: 79952121322     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00543.2010     Document Type: Article

References (55)

1. Bergmeyer HU. Methods of Enzymatic Analysis. Weinheim, Germany: Verlag Chemie, 1983, p. 211-213.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. Buchanan TA, Denno KM, Sipos GF, Sadler TW. Diabetic teratogenesis. In vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43: 656-660, 1994.
4. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315: 275-278, 1997. (Pubitemid 27326208)
5. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44: 766-774, 2001. (Pubitemid 32846032)
6. Cederberg J, Eriksson UJ. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis. Birth Defects Res A Clin Mol Teratol 73: 498-505, 2005. (Pubitemid 41045297)
7. Chang TI, Horal M, Jain SK, Wang F, Patel R, Loeken MR. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46: 538-545, 2003. (Pubitemid 36577799)
8. Cockroft DL, Coppola PT. Teratogenic effect of excess glucose on head-fold rat embryos in culture. Teratology 16: 141-146, 1977. (Pubitemid 8215225)
9. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409-2417, 2008.
10. Eriksson RS, Thunberg L, Eriksson UJ. Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats. Diabetes 38: 764-772, 1989. (Pubitemid 19285731)
11. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37: 365-374, 1988.
12. Eriksson UJ, Borg LAH. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42: 411-419, 1993.
13. Eriksson UJ, Borg LA. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34: 325-331, 1991.
14. Eriksson U, Dahlström E, Larsson KS, Hellerström C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31: 1-6, 1982. (Pubitemid 12254623)
15. Eriksson UJ, Naeser P, Brolin SE. Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes 35: 1356-1363, 1986. (Pubitemid 17199169)
16. Evers IM, de Valk HW, Visser GH. Male predominance of congenital malformations in infants of women with type 1 diabetes. Diabetes Care 32: 1194-1195, 2009.
17. Fine EL, Horal M, Chang TI, Fortin G, Loeken MR. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes 48: 2454-2462, 1999. (Pubitemid 30395439)
18. Frías JL, Frías JP, Frías PA, Martínez- Frías ML. Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet A 143: 2904-2909, 2007. (Pubitemid 350274803)
19. Gareskog M, Cederberg J, Eriksson UJ, Wentzel P. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos. Reprod Toxicol 23: 63-74, 2007. (Pubitemid 46027535)
20. Gareskog M, Wentzel P. Altered protein kinase C activation associated with rat embryonic dysmorphogenesis. Pediatr Res 56: 849-857, 2004. (Pubitemid 39552764)
21. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173: 1036-1041, 1995.
22. Hiramatsu Y, Sekiguchi N, Hayashi M, Isshiki K, Yokota T, King GL, Loeken MR. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 51: 2804-2810, 2002. (Pubitemid 34970934)
23. Hod M, Star S, Passonneau JV, Unterman TG, Freinkel N. Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun 140: 974-980, 1986. (Pubitemid 17207787)
24. Hoet JJ, Ozanne S, Reusens B. Influences of Pre- and Postnatal Nutritional Exposures on Vascular/Endocrine Systems in Animals. Environ Health Perspect 108: 563-568, 2000. (Pubitemid 30466183)
25. Li R, Thorens B, Loeken MR. Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia 50: 682-689, 2007. (Pubitemid 46215513)
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
27. Martínez-Frias ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 51: 108-113, 1994. (Pubitemid 24155223)
28. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304: 1331-1334, 1981. (Pubitemid 11113690)
29. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28: 292-293, 1979.
30. Molin DG, Roest PA, Nordstrand H, Wisse LJ, Poelmann RE, Eriksson UJ, Gittenberger-De Groot AC. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol 70: 927-938, 2004. (Pubitemid 40030369)
31. Nash P, Olovsson M, Eriksson UJ. Placental dysfunction in Suramin-treated rats: impact of maternal diabetes and effects of antioxidative treatment. J Soc Gynecol Investig 12: 174-184, 2005. (Pubitemid 40387810)
32. Ornoy A, Zaken V, Kohen R. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology 60: 376-386, 1999.
33. Otani H, Tanaka O, Tatewaki R, Naora H, Yoneyama T. Diabetic environment and genetic predisposition as causes of congenital malformations in NOD mouse embryos. Diabetes 40: 1245-1250, 1991.
34. Pampfer S, Vanderheyden I, McCracken JE, Vesela J, De Hertogh R. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development 124: 4827-4836, 1997. (Pubitemid 28014386)
35. Pani L, Horal M, Loeken MR. Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 51: 2871-2874, 2002. (Pubitemid 34970944)
36. Pani L, Horal M, Loeken MR. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 16: 676-680, 2002. (Pubitemid 34274036)
37. Pedersen J. The Pregnant Diabetic and Her Newborn. Problems and Management. Copenhagen: Munksgaard, 1977.
38. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46: 1189-1197, 1997. (Pubitemid 27271081)
39. Reece EA, Homko CJ. Prepregnancy care and the prevention of fetal malformations in the pregnancy complicated by diabetes. Clin Obstet Gynecol 50: 990-997, 2007. (Pubitemid 350059296)
40. Reece EA, Wu YK, Zhao Z, Dhanasekaran D. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 194: 580-585, 2006. (Pubitemid 43183719)
41. Sakamaki H, Akazawa S, Ishibashi M, Izumino K, Takino H, Yamasaki H, Yamaguchi Y, Goto S, Urata Y, Kondo T, Nagataki S. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48: 1138-1144, 1999. (Pubitemid 29226363)
42. Simán CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 61: 355-367, 2000. (Pubitemid 30258821)
43. Sivan E, Lee Y, Wu Y, Reece E. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56: 343-349, 1997. (Pubitemid 28066154)
44. Styrud J, Thunberg L, Nybacka O, Eriksson UJ. Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37: 343-353, 1995.
45. Sun F, Kawasaki E, Akazawa S, Hishikawa Y, Sugahara K, Kamihira S, Koji T, Eguchi K. Apoptosis and its pathway in early post-implantation embryos of diabetic rats. Diabetes Res Clin Pract 67: 110-118, 2005. (Pubitemid 40093020)
46. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Kondo T, Nagataki S. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44: 992-998, 1995.
47. Weksler-Zangen S, Yaffe P, Ornoy A. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res A Clin Mol Teratol 67: 429-437, 2003. (Pubitemid 38221991)
48. Wentzel P, Ejdesjö A, Eriksson UJ. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos. Diabetes 52: 1222-1228, 2003. (Pubitemid 36523360)
49. Wentzel P, Eriksson UJ. 8-Iso-PGF(2alpha) administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro. Teratology 66: 164-168, 2002.
50. Wentzel P, Eriksson UJ. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats. Eur J Endocrinol 134: 459-466, 1996. (Pubitemid 26155509)
51. Wentzel P, Welsh N, Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered PGE2 levels in rat embryos exposed to a diabetic environment. Diabetes 48: 813-820, 1999. (Pubitemid 29153081)
52. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63: 193-201, 2001. (Pubitemid 32417248)
53. Williams JW. The clinical significance of glycosuria in pregnant women. Am J Med Sci 137: 1-26, 1909.
54. Wu RR, Lyons PA, Wang A, Sainsbury AJ, Chung S, Palmer TN. Effects of galactose feeding on aldose reductase gene expression. J Clin Invest 92: 155-159, 1993. (Pubitemid 23208991)
55. Yang X, Borg LA, Eriksson UJ. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol Endocrinol Metab 272: E173-E180, 1997.